Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic
Top Cited Papers
Open Access
- 15 December 2020
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 214 (1), 23-30
- https://doi.org/10.5694/mja2.50883
Abstract
Objectives To describe the characteristics and outcomes of patients with COVID‐19 admitted to intensive care units (ICUs) during the initial months of the pandemic in Australia. Design, setting Prospective, observational cohort study in 77 ICUs across Australia. Participants Patients admitted to participating ICUs with laboratory‐confirmed COVID‐19 during 27 February – 30 June 2020. Main outcome measures ICU mortality and resource use (ICU length of stay, peak bed occupancy). Results The median age of the 204 patients with COVID‐19 admitted to intensive care was 63.5 years (IQR, 53–72 years); 140 were men (69%). The most frequent comorbid conditions were obesity (40% of patients), diabetes (28%), hypertension treated with angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers (24%), and chronic cardiac disease (20%); 73 patients (36%) reported no comorbidity. The most frequent source of infection was overseas travel (114 patients, 56%). Median peak ICU bed occupancy was 14% (IQR, 9–16%). Invasive ventilation was provided for 119 patients (58%). Median length of ICU stay was greater for invasively ventilated patients than for non‐ventilated patients (16 days; IQR, 9–28 days v 3 days; IQR, 2–5 days), as was ICU mortality (26 deaths, 22%; 95% CI, 15–31% v four deaths, 5%; 95% CI, 1–12%). Higher Acute Physiology and Chronic Health Evaluation II (APACHE‐II) scores on ICU day 1 (adjusted hazard ratio [aHR], 1.15; 95% CI, 1.09–1.21) and chronic cardiac disease (aHR, 3.38; 95% CI, 1.46–7.83) were each associated with higher ICU mortality. Conclusion Until the end of June 2020, mortality among patients with COVID‐19 who required invasive ventilation in Australian ICUs was lower and their ICU stay longer than reported overseas. Our findings highlight the importance of ensuring adequate local ICU capacity, particularly as the pandemic has not yet ended.Keywords
Funding Information
- Department of Health, Australian Government
This publication has 21 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Critical Care Utilization for the COVID-19 Outbreak in Lombardy, ItalyJAMA, 2020
- Critical care crisis and some recommendations during the COVID-19 epidemic in ChinaIntensive Care Medicine, 2020
- Potential association between COVID-19 mortality and health-care resource availabilityThe Lancet. Global Health, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States*Critical Care Medicine, 2012
- Critical Care Services and 2009 H1N1 Influenza in Australia and New ZealandThe New England Journal of Medicine, 2009
- Modeling Survival Data: Extending the Cox ModelPublished by Springer Science and Business Media LLC ,2000
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- APACHE IICritical Care Medicine, 1985